Vasomedical gets more time to comply with Nasdaq's bid price requirement

New York, Nov. 7 - Vasomedical, Inc. said that Nasdaq has given it more time to comply with the minimum bid price requirement.

The Westbury, N.Y., designer of non-invasive treatments for cardiovascular dysfunctions now has until April 27, 2006 instead of Oct. 31, 2005.

Nasdaq said the extension is because Vasomedical has met all the other requirements for continued listing, according to an 8-K filing with the Securities and Exchange Commission.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.